TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.

Cancer Reports
Quoc Thang PhamWataru Yasui

Abstract

Bladder cancer (BC) is the 10th most common cancer in the world. BC with muscle invasion results in a poor prognosis and is usually fatal. Cancer cell metabolism has an essential role in the development and progression of tumors. Expression of tryptophan 2,3-dioxygenase (TDO2) is associated with tumor progression and worse survival in some other cancers. However, no studies have been performed to uncover the biofunctional roles of TDO2 in BC. This study aim to investigate the clinicopathologic significance of TDO2 in BC. TDO2 expression was evaluated by qRT-PCR and immunohistochemistry in an integrated analysis with the Cancer Genome Atlas (TCGA) and other published datasets. TDO2 overexpression was significantly associated with T classification, N classification, and M classification, tumor stage, recurrence, and basal type, and with the expression of CD44 and aldehyde dehydrogenase 1 (ALDH1) in BC. High TDO2 expression correlated with poor outcome of BC patients. Using BC cell lines with knockdown and forced expression of TDO2, we found that TDO2 was involved in the growth, migration, and invasiveness of BC cells. Moreover, TDO2 was found to be crucial for spheroid formation in BC cells. Importantly, TDO2 promoted BC cells re...Continue Reading

References

Jan 2, 1993·International Journal of Cancer. Journal International Du Cancer·W YasuiE Tahara
May 6, 2009·Stem Cells·Shigeo TakaishiTimothy C Wang
Oct 15, 2009·Anti-cancer Drugs·Helmout Modjtahedi, Sharadah Essapen
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Oct 7, 2011·Nature·Christiane A OpitzMichael Platten
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Luc PilotteBenoît J Van den Eynde
Jan 31, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Feb 27, 2016·Journal of Cellular Biochemistry·Seog-Young KimYong J Lee
Nov 3, 2016·Nature Reviews. Clinical Oncology·Ubaldo E Martinez-OutschoornMichael P Lisanti
May 14, 2016·Oncology Reports·Naohide OueWataru Yasui
Jul 5, 2016·European Urology·J Alfred WitjesMaria J Ribal
Feb 17, 2017·Japanese Journal of Clinical Oncology·Tomohiro Matsuda, Ayako Okuyama
May 5, 2017·International Journal of Tryptophan Research : IJTR·Abdulla A-B Badawy
Oct 7, 2017·Nature Medicine·Eduard Batlle, Hans Clevers
Oct 11, 2017·Cell·A Gordon RobertsonSeth P Lerner
Dec 13, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mingxiang YeJian Zhang
Dec 20, 2017·Trends in Pharmacological Sciences·Jae Eun Cheong, Lijun Sun
Feb 8, 2018·International Review of Cell and Molecular Biology·George C PrendergastAlexander J Muller
Jun 26, 2018·Chemical Reviews·Jessica L CounihanDaniel K Nomura
Jan 24, 2019·Archives of Pathology & Laboratory Medicine·Charles C Guo, Bogdan Czerniak
Aug 21, 2019·Life Sciences·Masoud NajafiJamal Majidpoor
Dec 19, 2019·Frontiers in Oncology·Chiara ArientiAnna Tesei
Mar 7, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Thomas W FlaigAlyse Johnson-Chilla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.